Roche Postdoctoral Position in Neurodevelopmental Genomics of Drug Response (start July 2021, 2 years)

Dieses Inserat ist leider ausgelaufen
Aber es warten noch tausend andere spannende Inserate auf Dich.
Neue Suche starten

Roche Postdoctoral Position in Neurodevelopmental Genomics of Drug Response (start July 2021, 2 years)

As a post-doctoral fellow in Neuroscience & Rare Disease (NRD), you will have the privilege of assuming a dual and highly collaborative role in both the NRD Research and Biomarker and Translational Technologies units.

This position will be four-pronged in that the candidate will be tasked with the following

  • leverage internal and external genomics data to validate the implication of certain targets in Autism Spectrum Disorder;
  • design functional experiments to validate critical pharmacogenomics findings;
  • contribute to design and genomic findings related to multiple drug programs in the neurodevelopmental space;
  • contribute to the global gene therapy strategy within Neuroscience and Rare Disease by proposing novel targets and doing relevant due diligence.

Your main responsibilities will be

Plan and execute genomic analyses of internal and external cohorts of individuals ascertained for developmental delay and Autism Spectrum Disorders

Contribute to the overall strategy of different drug programs within the Neuroscience and Rare Disease portfolio, leveraging genomic data obtained through internal efforts and external collaborations

Design functional experiments in cell and animal models to follow-up on pharmacogenomics findings

Present your data to different stakeholders and teams within the company on a regular basis

Who you are

You have a doctoral degree conferred in human genetics or developmental biology

You have a strong grounding in the use of molecular genetic techniques and the study of neurodevelopmental disorders

Proficient in bioinformatics tools used to manipulate genomic data

You are experienced in molecular techniques including, but not restricted to: PCR, cloning, cell culture, tissue preparation, animal husbandry

Applicants with relevant previous industrial experience will be prioritized, as the role will require the candidate to interface with groups across research and biomarker divisions of Neuroscience and Rare Disease

Being driven and capable of independently executing analyses and having good communication skills are necessary, given the highly-collaborative nature of the position

The preferred start date is July 2021.

To be considered your application needs to include

  • A cover letter, a CV (including a list of relevant publications) and the names of three references

Are you ready to apply? We are looking for someone who thinks beyond the job offered - someone who knows that this position can be a rare springboard to many other opportunities at Roche. When applying for this position, already project yourself in the future. Think about what could come next and how you would like to build your future.

Roche embraces diversity and equal opportunity in a serious way. We are dedicated to building a team that represents a range of backgrounds, perspectives, and skills. The more inclusive we are, the better our work will be.

If you still have questions, then please check our FAQs and videos oncareers.roche.ch/faq

Tags: ROiQQ ROiLS ROiBT ROiMB ROiEE ROiBING

Wer wir sind

At Roche, 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.

Roche is an equal opportunity employer.

Job-Fakten

  • StandortSwitzerland,Basel-City,Basel
  • Funktion Research & Development
  • Subfunktion Research
  • Arbeitszeit Full time
  • Funktionsebene Entry Level
  • Art der Anstellung Graduate / Post-Graduate (Fixed Term)
  • Firma/ Division Roche Pharmaceuticals
  • Posted since 2021/03/31
  • Job-ID 202103-108472

Kontaktieren Sie uns

Mrs. Tina Hölzing

Online bewerben!

Am 21.04.2021 veröffentlicht. Originalanzeige